首页 | 本学科首页   官方微博 | 高级检索  
     

阿苯达唑葡聚糖纳米颗粒大鼠体内药动学和小鼠肝脏靶向性研究
引用本文:杨海山,朱吉海,赵玲莉,张翔,郑鹏善,张志平,周勇君,李永臻,刘燕. 阿苯达唑葡聚糖纳米颗粒大鼠体内药动学和小鼠肝脏靶向性研究[J]. 中国医院药学杂志, 2022, 42(4): 408-415. DOI: 10.13286/j.1001-5213.2022.04.12
作者姓名:杨海山  朱吉海  赵玲莉  张翔  郑鹏善  张志平  周勇君  李永臻  刘燕
作者单位:1. 青海大学医学院基础医学研究中心, 青海 西宁 810016;2. 青海大学附属医院检验科, 青海 西宁 810001;3. 青海大学医学院免疫教研室, 青海 西宁 810016
基金项目:青海省科技厅基础研究项目资助(编号:2017-ZJ-735)
摘    要:目的:以葡聚糖纳米颗粒(glucan particles,GPs)负载阿苯达唑(albendazole,ABZ)得到的阿苯达唑葡聚糖纳米颗粒(ABZ-GPs)为研究对象,探索其在大鼠体内药动学特征及对小鼠肝脏的靶向性.方法:大鼠和小鼠分别灌胃给予ABZ和ABZ-GPs,并于给药后不同时间点从大鼠眼脉络丛取血、小鼠解剖取...

关 键 词:葡聚糖纳米颗粒  阿苯达唑  药动学  肝靶向性
收稿时间:2021-07-22

Pharmacokinetics and liver targeting ability of albendazole-glucan particles
YANG Hai-shan,ZHU Ji-hai,ZHAO Ling-li,ZHANG Xiang,ZHENG Peng-shan,ZHANG Zhi-ping,ZHOU Yong-jun,LI Yong-zhen,LIU Yan. Pharmacokinetics and liver targeting ability of albendazole-glucan particles[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(4): 408-415. DOI: 10.13286/j.1001-5213.2022.04.12
Authors:YANG Hai-shan  ZHU Ji-hai  ZHAO Ling-li  ZHANG Xiang  ZHENG Peng-shan  ZHANG Zhi-ping  ZHOU Yong-jun  LI Yong-zhen  LIU Yan
Affiliation:1. Research Center of Basic Medical Science, Medical College of Qinghai University, Qinghai Xining 810016, China;2. Department of Laboratory Medicine, Affiliated Hospital of Qinghai University, Qinghai Xining 810001, China;3. Department of Immunology, Medical College of Qinghai University, Qinghai Xining 810001, China
Abstract:OBJECTIVE Glucan particles(GPs) are used for preparing albendazole-GPs(ABZ-GPs) to study the pharmacokinetics of albendazole-glucan particles in rats and liver distribution specificity in mice.METHODS Rats and mice were administrated albendazole and albendazole-glucan particles by gavage, respectively.Blood taken from the choroid plexus of the rat eyes and the liver was obtained from the mice at different time points after the administration.After the liver and blood samples were processed with different methods, LC-MS/MS was used to measure the drug concentration in these samples, and the pharmacokinetic parameters as well as the liver targeting ability of the two drugs were analyzed.RESULTS The established LC-MS/MS method had a good linear relationship in the determination of drug content in plasma and liver tissue.The intra-day and inter-day precision and stability RSD of the standard product was less than 11%, and the recovery rate of the extraction method was more than (83.85±0.91)%.The pharmacokinetic parameters of the active-components-albendazole sulfoxide from the ABZ-GPs were Cmax=(0.86±0.07) μg·h·mL-1, tmax=(8.00±0.35) h, AUC0-t=(8.60±1.72) μg·h·mL-1, MRT0-t=(7.00±0.87) h;the maximum of ABZSO concentration ratio(Ce) of ABZ-GPs/ABZ in mouse liver tissue was 1.32, and the targeting index(TI) of ABZ-GPs/ABZ was 3.27.CONCLUSION Compared to the original drug albendazole, albendazole-glucan particles were absorbed more quickly in rats, also has better-liver targeting ability and obvious sustained-release effects in mice.
Keywords:glucan particles  albendazole  pharmacokinetics  liver targeting  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号